China files appeal in U.S. anti-dumping case: WTO
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
People talk outside the headquarters of the World Trade Organization (WTO) in Geneva, Switzerland, June 3, 2016. REUTERS/Denis Balibouse
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
GENEVA (Reuters) - China has filed an appeal against a ruling by the World Trade Organization (WTO) in a dispute over methodologies used by the United States to calculate anti-dumping tariffs targeting Chinese imports, a WTO statement said.
In the dispute panel ruling released last month, China won the bulk of its WTO complaint brought in 2013 against certain U.S. methods of determining anti-dumping duties on Chinese products.
But some points of China's argument were rejected by the WTO panel, including a claim that the U.S. Commerce Department systematically punishes Chinese state enterprise by assigning them high anti-dumping rates.
Dumping is normally found when a foreign producer's U.S. prices are lower than its home market prices for the same or similar goods, or when the imports are sold at prices below production costs.
(Reporting by Stephanie Nebehay; Editing by Catherine Evans)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'It's made in Vietnam!' At inauguration, origin of red Trump hats shocks many
- Merger activity for independent U.S. wealth managers up 10 percent: study
- U.S. soldier Bergdahl seeks charge dismissal over Trump comments
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!